Trial Profile

A multi-centre, randomised, placebo-controlled, double-blind, parallel-group study on the efficacy and safety of WF10 and its main constituents in patients with refractory allergic rhinitis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs WF 10 (Primary)
Indications Allergic rhinitis
Focus Proof of concept; Therapeutic Use
Acronyms 2014 WF10 Trial
Sponsors Nuvo Research

Most Recent Events

08 Jun 2015 Results published in a Nuvo Research media release.
08 Jun 2015 Status changed from active, no longer recruiting to completed according to a Nuvo Research media release.
05 Mar 2015 Top-line results discussed in Nuvo Research media release and compared with results of the 2010 trial; unblinded follow-up will continue for 24 weeks post-treatment.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com